Used primarily in pharmaceutical research, this compound is a derivative of thalidomide and acts as an immunomodulatory agent. It functions by enhancing the degradation of specific proteins involved in inflammation and cancer progression, making it valuable in the development of treatments for multiple myeloma and other hematological malignancies. Its alkyne group allows for further chemical modifications through click chemistry, enabling targeted drug delivery systems and the creation of novel conjugates for improved therapeutic efficacy. It is also investigated for its anti-angiogenic and anti-inflammatory properties in preclinical studies.